GeneInCell
by Vinod Reddy Lekkala
Latest episode
Optogenetics Wins the 2026 Nobel Prize- Controlling the Brain with…
Optogenetics Wins the 2026 Nobel Prize- Controlling the Brain with…
About this podcast
GeneInCell-The AI-powered Biotech Podcast focuses on crisp, science-based podcasts on stem cells, organoids, and gene editing—tracking breakthroughs from bench to bedside for better human health, including Biotech and business.
Episodes
The newest 20 of 42 episodes
- Optogenetics Wins the 2026 Nobel Prize- Controlling the Brain with Light | GeneInCell | 2026 · 51 min · Season 2 Episode 21Optogenetics has transformed neuroscience by letting scientists control specific nerve cells with light. In this episode, we explore the discoveries behind the 2026 Nobel Prize…
- AlphaGenome: Finding Disease in the Dark Genome | GeneInCell | 2026 · 45 min · Season 2 Episode 20AlphaGenome Atlas is helping decode the 98% of the human genome that doesn’t code for proteins. By predicting how non-coding variants affect transcription, splicing, chromatin…
- Can mRNA Vaccines Fight Cancer? | GeneInCell | 2026 · 55 min · Season 2 Episode 19Can mRNA vaccines train the immune system to recognize and attack cancer? In this episode, we explore how mRNA cancer vaccines are designed, how they deliver tumor-specific…
- Anti-Aging Peptides- Can We Slow the Biology of Aging? | GeneInCell | 2026 · 1 h 3 min · Season 2 Episode 18Can peptides help slow the biological processes of aging? In this episode, we explore how anti-aging peptides may influence cellular repair, inflammation, metabolism, collagen…
- The Cellular Clock: Telomerase and the Science of Slowing Aging | Longevity | GeneInCell · 1 h 2 min · Season 2 Episode 17Telomerase helps protect the ends of chromosomes, but its role in aging is complex. In this episode, we explore how telomeres influence cellular lifespan, whether activating…
- Can Epigenetic Reprogramming Reverse Aging? | GeneInCell | 2026 · 58 min · Season 2 Episode 16Epigenetic reprogramming is emerging as one of the most intriguing ideas in aging research—the possibility that aging is not just damage, but also a reversible loss of cellular…
- Chemical Antibodies: How Aptamers Could Transform Future Therapies | GeneInCell | 2026 · 57 min · Season 2 Episode 15Aptamers are emerging as powerful “chemical antibodies” that can bind targets with high precision while offering advantages in design, synthesis, and stability. In this episode…
- Antisense Oligonucleotides: Programming RNA to Silence Disease | GeneInCell | 2026 · 57 min · Season 2 Episode 14Antisense oligonucleotides are redefining medicine by programming RNA to silence disease at its source. In this episode, we explore how these short, sequence-designed molecules…
- Silencing Genetic Disease with shRNA | GeneInCell | 2026 · 1 h 3 min · Season 2 Episode 13shRNA is a gene-silencing tool that uses the cell’s own RNA interference machinery to reduce harmful protein production. In this episode, we explore how short hairpin RNAs are…
- Base Editing- Rewriting DNA One Letter at a Time | GeneInCell | 2026 · 55 min · Season 2 Episode 12Base editing is changing the future of gene editing by allowing scientists to rewrite DNA one letter at a time. In this episode, we explore how base editors work, why they offer…
- siRNAs: Programmable Drugs for Silencing Genetic Disease | GeneInCell · 1 h 5 min · Season 2 Episode 11siRNAs are transforming medicine by acting as programmable drugs that selectively silence disease-causing genes. In this episode, we explore how small interfering RNAs work…
- Prime editing: Search and replace for human DNA | GeneInCell | 2026 · 58 min · Season 2 Episode 10Prime editing is a next-generation gene editing tool designed to precisely rewrite DNA—like a search-and-replace function for the human genome. In this episode, we break down how…
- New Approach Methodologies (NAMs) for Replacing Animal Models in Drug Discovery | GeneInCell | 2026 · 45 min · Season 2 Episode 9NAMs are changing how new drugs are developed. We discuss organoids, tissue chips, and AI-based tools, along with the growing FDA and NIH push toward more human-relevant methods…
- Growing replacement kidneys from stem cells | GeneInCell | 2026 · 52 min · Season 2 Episode 8Can we grow new kidneys from stem cells? In this episode, we explore how scientists are using pluripotent stem cells to create kidney organoids that mimic early kidney…
- Is Space Travel Safe For You? | GeneInCell | 2026 · 49 min · Season 2 Episode 7What really happens to your cells under stress, in space, and during space travel? In this episode, we zoom in on the physiological, cellular, and molecular levels to uncover how…
- Growing Beating Human Hearts in a Dish | Heart Organoids | GeneInCell · 16 min · Season 2 Episode 6What does it take to grow a beating human heart in the lab? This episode explores cardiac organoids—self-organizing heart tissues derived from human stem cells that contract…
- The AI Revolution in Healthcare: 2026 Innovation and Trends | GeneInCell | 2026 · 35 min · Season 2 Episode 5In this episode, we explore the AI revolution in healthcare and what 2026 could look like—from smarter diagnostics and personalized treatments to automation that reshapes…
- Engineering the Next Wave of Innovation with Synthetic Biology | GeneInCell | 2026 · 33 min · Season 2 Episode 4Synthetic biology is turning cells into programmable factories, sensors, and therapies. In this episode, we explore how DNA can be engineered like code to build smarter…
- Engineering Blood Vessels for Human Mini Brains | Vascularized Human Brain Organoids | GeneInCell | 2026 · 37 min · Season 2 Episode 3How do you give “mini-brains” a bloodstream? This episode explores vascular brain organoids—cerebral organoids engineered with endothelial cells, pericytes, and astrocytes to…
- Growing Biological Computers-Brain Organoids From Human Cells | GeneInCell · 27 min · Season 2 Episode 2Brain organoids are self-organizing “mini-brains” grown from human stem cells that recapitulate key aspects of early neural development. They fire neural networks on MEAs, model…







